Press Releases

Jun 03, 2020
Covalon Granted Key Antimicrobial Patents in the United States, Canada, and Europe
MISSISSAUGA, ON , June 3, 2020 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that the Company has been granted key antimicrobial patents by the United States Patent and Trademark Office ("USPTO"),
May 29, 2020
Covalon Delays Filing of Interim Financial Statements Due to Delays Related to COVID-19 and Provides Business Update
MISSISSAUGA, ON , May 29, 2020 /CNW/ -  Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced today that it is relying on the exemption provided in Ontario Instrument 51-502 Temporary Exemption from Certain Corporate
Apr 27, 2020
Amir Boloor Joins Covalon’s Board of Directors
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 27, 2020-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is delighted to announce that Mr. Amir Boloor has joined its Board of Directors.
Apr 23, 2020
Martin Goldfarb, O.C., Joins Covalon’s Board of Directors
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 23, 2020-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is delighted to announce that Mr. Martin Goldfarb has joined its Board of Directors.
Apr 14, 2020
Covalon Postpones Annual Meeting of Shareholders Due to COVID-19
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 14, 2020-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announces today that given the extraordinary circumstances of the ongoing COVID-19 pandemic and the resulting
Apr 03, 2020
Covalon Announces Conference Call to Discuss New CovaGuard Antimicrobial Technology
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Apr. 3, 2020-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announces a conference call to further discuss its new CovaGuard antimicrobial technology.
Mar 31, 2020
Covalon Clarifies Previous Press Release
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 31, 2020-- At the request of IIROC, Investment Industry Regulatory Organization of Canada , Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has been asked to clarify the press
Mar 31, 2020
Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Mar. 31, 2020-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announces today its new breakthrough antimicrobial technology formulated to kill the COVID-19 virus (or “SARS-CoV-2”)
Mar 02, 2020
Covalon Announces First Quarter Fiscal 2020 Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces its first quarter fiscal 2020 results. Brian Pedlar , Covalon’s President and CEO, said, “I am pleased that
Feb 28, 2020
Covalon Announces Conference Call to Discuss First Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2020 First Quarter financial results on Monday, March 2 nd , 2020, after markets close.
Jan 28, 2020
Covalon Announces Fiscal 2019 Year-End Results and Plans for Fiscal 2020
Fiscal 2019 revenue growth of 27% to $34 million of revenue. Fiscal 2019 United States revenue of $24 million , double the Company’s fiscal 2018 United States revenue.  Fiscal 2019 Middle East revenue of $8.8 million impacted by delayed shipments and regional uncertainty.  Latin America and Europe
Jan 27, 2020
Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results
MISSISSAUGA, Ontario --(BUSINESS WIRE)--Jan. 27, 2020-- Covalon Technologies Ltd. (the "Company" or " Covalon ") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Fiscal 2019 Fourth Quarter and Year-End financial results concurrently on Tuesday, January 28 th ,